R S Mirzoian Selected Research

2- ((2- morpholino)ethylthio)- 5- ethoxybenzimidazole

1/2014	[Cerebrovascular pharmacology of separate and combined vascular pathology of brain and heart].
5/2010	[Cerebrovascular effects of afobazole under conditions of combined disorders of cerebral and coronary circulation].
11/2009	[Afobazole effect on cerebral circulation under hemorrhagic stroke model conditions].
1/2009	[Effects of afobazole on the stress protein HSP70 level in the brain tissue of rats with global transient ischemia].
7/2006	[Effect of afobazole on the accumulation of free radical oxidation products and the catalase activity in rats with cerebral ischemia].
9/2004	[Afobazole increases cerebral blood flow in rats with global brain ischemia].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

R S Mirzoian Research Topics

Disease

11	Ischemia 01/2014 - 07/2006
10	Brain Ischemia (Cerebral Ischemia) 01/2014 - 01/2003
7	Transient Ischemic Attack 01/2015 - 07/2004
6	Myocardial Infarction 01/2014 - 03/2009
2	Brain Injuries (Brain Injury) 01/2014 - 03/2003
1	Acidosis 01/2014
1	Hyperglycemia 01/2014
1	Cardiac Arrhythmias (Arrythmia) 01/2013
1	Hemorrhagic Stroke 11/2009
1	Myocardial Ischemia (Ischemic Heart Diseases) 03/2009

Drug/Important Bio-Agent (IBA)

6	2- ((2- morpholino)ethylthio)- 5- ethoxybenzimidazoleIBA 01/2014 - 09/2004
6	gamma-Aminobutyric Acid (GABA)IBA 01/2014 - 03/2003
5	Pharmaceutical PreparationsIBA 10/2010 - 01/2003
4	emoxypine succinateIBA 01/2014 - 10/2010
3	Nimodipine (Modus)FDA LinkGeneric 01/2014 - 03/2009
2	AcidsIBA 01/2014 - 01/2013
2	Arachidonic Acid (Vitamin F)IBA 01/2014 - 01/2011
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2014 - 03/2003
2	MelatoninIBA 01/2014 - 01/2012
2	BicucullineIBA 01/2013 - 11/2009
2	3,16-dihydroxyandrost-5-ene-17,19-dioneIBA 01/2012 - 07/2008
2	salicylhydroxamic acid (SHAM)IBA 05/2010 - 03/2009
1	Docosahexaenoic AcidsIBA 01/2015
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2014
1	amlodipine nicotinateIBA 01/2014
1	Dopamine (Intropin)FDA LinkGeneric 01/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2014
1	LipidsIBA 01/2014
1	Oxygen (Dioxygen)IBA 01/2014
1	Dizocilpine Maleate (Dizocilpine)IBA 01/2014
1	Dinoprostone (PGE2)FDA Link 01/2013
1	Calcium Chloride (Calcium Chloride, Anhydrous)FDA LinkGeneric 01/2013
1	AconitineIBA 01/2013
1	GABA-A Receptors (GABA(A) Receptor)IBA 01/2013
1	AdamantaneIBA 01/2012
1	3- (3,4,5- trimethoxybenzoyloximino)- 8- methyl- 8- azabicyclo(3,2,1)octaneIBA 01/2011
1	6-methyl-2-ethyl-3-hydroxypyridineIBA 01/2011
1	GABA Receptors (GABA Receptor)IBA 11/2009
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2009
1	CatalaseIBA 07/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2006
1	EnzymesIBA 07/2006
1	Free RadicalsIBA 07/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 03/2003
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 01/2003
1	Pyrrolidinones (Pyrrolidones)IBA 01/2003

Therapy/Procedure

1	Lasers (Laser) 01/2015
1	Hemoperfusion 01/2013
1	Ligation 09/2004
1	Drug Therapy (Chemotherapy) 03/2003